Selected research
Industry Research
Ropivacaine Injection Industry Research Report 2026
Market perspective
The global Ropivacaine Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ropivacaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ropivacaine Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ropivacaine Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ropivacaine Injection include Zhejiang Xianju Pharmaceutical Co.,Ltd, Yangzi River Pharmaceutical Group, Jiangsu Nhwa Pharmaceutical Co.,Ltd., Jiangsu Nhwa Pharmaceutical Co.,Ltd, Pfizer, Jiangsu Hengrui Pharmaceuticals Co., Ltd., AstraZeneca, Sintetica SA and SGPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ropivacaine Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ropivacaine Injection Market by Company
Zhejiang Xianju Pharmaceutical Co.,Ltd
Yangzi River Pharmaceutical Group
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Pfizer
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
AstraZeneca
Sintetica SA
SGPharma
Nephron Pharmaceuticals
Manus Aktteva Biopharma LLP
Anant Pharmaceuticals
Akorn
Ropivacaine Injection Segment by Type
10 mg/mL (1%)
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
Ropivacaine Injection Segment by Application
Major Nerve Block
Surgical Anesthesia
Acute Pain Management
Other
Ropivacaine Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ropivacaine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ropivacaine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ropivacaine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ropivacaine Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ropivacaine Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ropivacaine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10 mg/mL (1%)
- 2 mg/mL (0.2%)
- 5 mg/mL (0.5%)
- 7.5 mg/mL (0.75%)
Applications
- Major Nerve Block
- Surgical Anesthesia
- Acute Pain Management
- Other
Companies covered
- Zhejiang Xianju Pharmaceutical Co.,Ltd
- Yangzi River Pharmaceutical Group
- Jiangsu Nhwa Pharmaceutical Co.,Ltd.
- Jiangsu Nhwa Pharmaceutical Co.,Ltd
- Pfizer
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- AstraZeneca
- Sintetica SA
- SGPharma
- Nephron Pharmaceuticals
- Manus Aktteva Biopharma LLP
- Anant Pharmaceuticals
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ropivacaine Injection Market Size (2021-2032)
- 2.2.2 Global Ropivacaine Injection Sales (2021-2032)
- 2.2.3 Global Ropivacaine Injection Market Average Price (2021-2032)
- 2.3 Ropivacaine Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10 mg/mL (1%)
- 2.3.3 2 mg/mL (0.2%)
- 2.3.4 5 mg/mL (0.5%)
- 2.3.5 7.5 mg/mL (0.75%)
- 2.4 Ropivacaine Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Major Nerve Block
- 2.4.3 Surgical Anesthesia
- 2.4.4 Acute Pain Management
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ropivacaine Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ropivacaine Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Ropivacaine Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Ropivacaine Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Ropivacaine Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ropivacaine Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ropivacaine Injection, Product Type & Application
- 3.8 Global Manufacturers of Ropivacaine Injection, Established Date
- 3.9 Global Ropivacaine Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Xianju Pharmaceutical Co.,Ltd
- 4.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
- 4.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
- 4.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio
- 4.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
- 4.2 Yangzi River Pharmaceutical Group
- 4.2.1 Yangzi River Pharmaceutical Group Company Information
- 4.2.2 Yangzi River Pharmaceutical Group Business Overview
- 4.2.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Product Portfolio
- 4.2.5 Yangzi River Pharmaceutical Group Recent Developments
- 4.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
- 4.3.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information
- 4.3.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Business Overview
- 4.3.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product Portfolio
- 4.3.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments
- 4.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd
- 4.4.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information
- 4.4.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Business Overview
- 4.4.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio
- 4.4.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Ropivacaine Injection Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 4.6.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
- 4.6.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
- 4.6.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product Portfolio
- 4.6.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
- 4.7 AstraZeneca
- 4.7.1 AstraZeneca Company Information
- 4.7.2 AstraZeneca Business Overview
- 4.7.3 AstraZeneca Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AstraZeneca Ropivacaine Injection Product Portfolio
- 4.7.5 AstraZeneca Recent Developments
- 4.8 Sintetica SA
- 4.8.1 Sintetica SA Company Information
- 4.8.2 Sintetica SA Business Overview
- 4.8.3 Sintetica SA Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sintetica SA Ropivacaine Injection Product Portfolio
- 4.8.5 Sintetica SA Recent Developments
- 4.9 SGPharma
- 4.9.1 SGPharma Company Information
- 4.9.2 SGPharma Business Overview
- 4.9.3 SGPharma Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SGPharma Ropivacaine Injection Product Portfolio
- 4.9.5 SGPharma Recent Developments
- 4.10 Nephron Pharmaceuticals
- 4.10.1 Nephron Pharmaceuticals Company Information
- 4.10.2 Nephron Pharmaceuticals Business Overview
- 4.10.3 Nephron Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nephron Pharmaceuticals Ropivacaine Injection Product Portfolio
- 4.10.5 Nephron Pharmaceuticals Recent Developments
- 4.11 Manus Aktteva Biopharma LLP
- 4.11.1 Manus Aktteva Biopharma LLP Company Information
- 4.11.2 Manus Aktteva Biopharma LLP Business Overview
- 4.11.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Product Portfolio
- 4.11.5 Manus Aktteva Biopharma LLP Recent Developments
- 4.12 Anant Pharmaceuticals
- 4.12.1 Anant Pharmaceuticals Company Information
- 4.12.2 Anant Pharmaceuticals Business Overview
- 4.12.3 Anant Pharmaceuticals Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Anant Pharmaceuticals Ropivacaine Injection Product Portfolio
- 4.12.5 Anant Pharmaceuticals Recent Developments
- 4.13 Akorn
- 4.13.1 Akorn Company Information
- 4.13.2 Akorn Business Overview
- 4.13.3 Akorn Ropivacaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Akorn Ropivacaine Injection Product Portfolio
- 4.13.5 Akorn Recent Developments
5 Global Ropivacaine Injection Market Scenario by Region
- 5.1 Global Ropivacaine Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ropivacaine Injection Sales by Region: 2021-2032
- 5.2.1 Global Ropivacaine Injection Sales by Region: 2021-2026
- 5.2.2 Global Ropivacaine Injection Sales by Region: 2027-2032
- 5.3 Global Ropivacaine Injection Revenue by Region: 2021-2032
- 5.3.1 Global Ropivacaine Injection Revenue by Region: 2021-2026
- 5.3.2 Global Ropivacaine Injection Revenue by Region: 2027-2032
- 5.4 North America Ropivacaine Injection Market Facts & Figures by Country
- 5.4.1 North America Ropivacaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ropivacaine Injection Sales by Country (2021-2032)
- 5.4.3 North America Ropivacaine Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ropivacaine Injection Market Facts & Figures by Country
- 5.5.1 Europe Ropivacaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ropivacaine Injection Sales by Country (2021-2032)
- 5.5.3 Europe Ropivacaine Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ropivacaine Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ropivacaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ropivacaine Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ropivacaine Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ropivacaine Injection Market Facts & Figures by Country
- 5.7.1 South America Ropivacaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ropivacaine Injection Sales by Country (2021-2032)
- 5.7.3 South America Ropivacaine Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Ropivacaine Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ropivacaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ropivacaine Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ropivacaine Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ropivacaine Injection Sales by Type (2021-2032)
- 6.1.1 Global Ropivacaine Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Ropivacaine Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Ropivacaine Injection Revenue by Type (2021-2032)
- 6.2.1 Global Ropivacaine Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ropivacaine Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Ropivacaine Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ropivacaine Injection Sales by Application (2021-2032)
- 7.1.1 Global Ropivacaine Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Ropivacaine Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Ropivacaine Injection Revenue by Application (2021-2032)
- 7.2.1 Global Ropivacaine Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ropivacaine Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Ropivacaine Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ropivacaine Injection Value Chain Analysis
- 8.1.1 Ropivacaine Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ropivacaine Injection Production Mode & Process
- 8.2 Ropivacaine Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ropivacaine Injection Distributors
- 8.2.3 Ropivacaine Injection Customers
9 Global Ropivacaine Injection Analyzing Market Dynamics
- 9.1 Ropivacaine Injection Industry Trends
- 9.2 Ropivacaine Injection Industry Drivers
- 9.3 Ropivacaine Injection Industry Opportunities and Challenges
- 9.4 Ropivacaine Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst